The role of intratumoral and systemic IL-6 in breast cancer.
about
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerWound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancerHow sleep and wakefulness influence circadian rhythmicity: effects of insufficient and mistimed sleep on the animal and human transcriptomeAssociation between the dietary inflammatory index and breast cancer in a large Italian case-control studyBET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathwaysIl-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migrationExploiting human and mouse transcriptomic data: Identification of circadian genes and pathways influencing health.The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patientsSerum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.The effect of exercise training on the level of tissue IL-6 and vascular endothelial growth factor in breast cancer bearing miceChallenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerModification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival.Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells.Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade.Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations.Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular developmentThe cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.Paracrine Interactions between Adipocytes and Tumor Cells Recruit and Modify Macrophages to the Mammary Tumor Microenvironment: The Role of Obesity and Inflammation in Breast Adipose TissueAcquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loopAdipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 productionPlacental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells.Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model.Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort.Cancers in Australia in 2010 attributable to overweight and obesityAnalysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes.Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanismLapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblastsConstitutive activation of STAT3 in breast cancer cells: A review.Significance of Interleukin-6 in Papillary Thyroid Carcinoma.Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown.Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache.Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expressionHuman breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation.Prospective association between dietary fiber intake and breast cancer riskImmune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation.
P2860
Q26769917-81C877B3-93CC-4456-8252-11081C70DCFAQ27023599-121A5FA4-2E0E-4296-B60A-BF50651480B1Q28081994-3E7B2E63-6F97-44A7-8B2C-9B35FAD093FCQ29248213-FC91EC8D-168C-4DDF-A332-230DB85F9B4CQ30248629-6957CFA5-FB4A-4125-BEB1-D55EA71E8BF2Q30572945-411EACF7-E2A7-44FE-AD23-DB75BE4D7F17Q30660919-BAC01E7D-F93A-4A4B-BF75-EF4B939DF0C5Q30910326-DCE07870-C6DD-42D0-BB4C-BB8B991186E3Q33613591-4F27C006-7439-4D1C-BCF5-57FC9DFE8DF0Q33686729-DBFFD5C7-DF3C-48D2-A9BC-5EC0D60B9638Q33713934-BD945071-A2F2-4B30-B5D0-D7DBD0E9C615Q33760216-1BF654A0-69F3-4F23-A5A9-56BC9B10BC5BQ33773047-CDFA2E0E-E6B4-4B39-AE30-611813786585Q34056571-5E3D222D-4169-47FB-B582-F1B122CCB8B3Q34281252-9D7F6E5D-745A-4D93-886D-F21C9C87C0C8Q34309582-C75CFFE7-A785-4F74-9224-4859818FE283Q34355992-C93CB856-B008-49DF-8319-A7AF69E81346Q34467457-6D367074-0568-4520-B56B-3D792156F796Q34516665-E6FBD1AA-114B-4D3F-8ED5-50AABC493277Q34786543-735CBB48-64B4-4AE0-9780-1FCD903DD717Q35237496-FA5B1A50-4AFC-45CF-B9B0-D97B830FFD6AQ35741610-6F64E4BD-EE60-4792-885A-BA9F0ED5AED9Q35781395-9A752A19-D52B-4754-B515-78F5474D384EQ35996338-D2BD5009-5F6A-4E27-823D-F9B6F6AFDC0EQ36047368-3706797C-979C-462A-B187-197AD83BAD2EQ36071192-19102020-A00F-46A9-9095-3198DC0558F1Q36164292-408FBA5A-B8A9-4D78-9B49-27BCA1355057Q36288549-6E802B62-55C9-4B84-A9EE-0AAE09EF97EBQ36319849-41E0F75E-6703-4B4D-A220-1DEA1E083ECEQ36545926-98B484B5-A303-4735-BD6E-F2F7CF2966EAQ36557492-E45F34B1-A255-42A1-AF3F-C6B0CF3ED7B3Q36711689-3580878E-D19E-4154-B63A-C4539776C5E2Q36731164-7CC6DF75-BCBE-45CA-9F0B-8DA4C1ACB6CAQ36758456-D5EAEADA-6170-478D-A167-A805A722BE4DQ36901996-6857BD9A-DF5F-4BA6-9CAA-FD07FD5DF6D4Q36944764-E158C95B-E61D-4AB3-AFC2-B91F8423EA58Q37117208-ADA18FE9-59C0-40B9-9A88-1A51A3F3F3A6Q37262555-E37F5F66-6871-4258-B6BD-EB1AE97F090AQ37308789-EEDE5223-0205-40CD-9213-F2C9DE97005AQ37383985-06E4B203-4EE9-4EC6-9F0F-D1326A627295
P2860
The role of intratumoral and systemic IL-6 in breast cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of intratumoral and systemic IL-6 in breast cancer.
@en
type
label
The role of intratumoral and systemic IL-6 in breast cancer.
@en
prefLabel
The role of intratumoral and systemic IL-6 in breast cancer.
@en
P2093
P2860
P1476
The role of intratumoral and systemic IL-6 in breast cancer.
@en
P2093
Christine Dethlefsen
Grith Højfeldt
Pernille Hojman
P2860
P2888
P304
P356
10.1007/S10549-013-2488-Z
P407
P577
2013-03-27T00:00:00Z
P6179
1022239913